Corbus Pharmaceuticals Inc.

CRBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.65

+$0.17 (+2.27%)

At close: Sep 21, 2026, 4:00 PM ET

$7.53

-$0.12 (-1.58%)

Pre-market: Sep 22, 2026, 9:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	881.71K	3.94M
Cost of Revenue	n/a	600K	n/a	1.49M	1.64M	n/a
Gross Profit	n/a	-600K	n/a	-1.49M	-757.53K	3.94M
Operating Income	-85.31M	-48.72M	-45.08M	-34.84M	-55.99M	-122.81M
Interest Income	5.53M	6.31M	n/a	n/a	n/a	n/a
Pretax Income	-78.54M	-40.21M	-44.6M	-42.35M	-45.64M	-111.27M
Net Income	-78.54M	-40.21M	-44.6M	-55.83M	-45.55M	-111.27M
Selling & General & Admin	15.22M	16.5M	13.91M	18.7M	20.43M	28.48M
Research & Development	70.1M	32.22M	31.17M	16.14M	36.45M	98.27M
Other Expenses	n/a	-600K	n/a	-1.49M	-1.64M	n/a
Operating Expenses	85.31M	48.12M	45.08M	33.35M	55.23M	126.75M
Interest Expense	n/a	1.87M	2.92M	2.13M	1.83M	1.03M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	85.31M	48.72M	45.08M	34.84M	56.87M	126.75M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.32M	10.92M	4.33M	4.17M	4.1M	2.6M
Shares Outstanding (Diluted)	13.32M	10.92M	4.33M	4.17M	4.1M	2.6M
EPS (Basic)	-5.90	-3.68	-10.31	-10.15	-11.13	-42.72
EPS (Diluted)	-5.90	-3.68	-10.31	-10.15	-11.13	-42.72
EBITDA	-78.3M	-37.74M	-40.11M	-38.73M	-42.17M	-121.12M
EBIT	-78.54M	-38.34M	-40.75M	-40.21M	-43.81M	-122.81M
Depreciation & Amortization	233K	600K	641K	1.49M	1.64M	1.69M